Tricuspid Regurgitation

FDA Approves Abbott’s TriClip Heart Valve Repair Device

The US Food and Drug Administration (FDA) on Tuesday, April 2, 2024, approved Abbott’s TriClip transcatheter edge-to-edge repair (TEER) system for use in leaky tricuspid heart valves.